Catalyst Contributors

Salvatore (“Salvo”) Alesci, M.D., Ph.D. joined PhRMA in December 2011 as Vice President, Scientific Affairs. In this role, Dr. Alesci serves as the primary expert for PhRMA on scientific and medical issues. He carries overall responsibility for establishing PhRMA as a “go to” source for input on policies and legislation related to innovative approaches to biopharmaceutical discovery and development. Dr.

2013 Research and Hope Awards Program Brochure

Dr. Bill Chin

Dr. Bill Chin leads PhRMA’s Scientific & Regulatory Affairs department. A physican, an endocrinologist and an academic at heart, Dr. Chin envisions establishing PhRMA as the premiere convener in advancing drug discovery and development, regulatory sciences and collaborative partnerships.

Conversations Contributors - Randy Beranek

Randy Beranek joined the National Psoriasis Foundation as its President and CEO in May, 2008 bringing with him more than 28 years of executive-level experience in the national, nonprofit health industry.

Conversations Contributors - Bob Blancato

Bob Blancato is President of Matz Blancato and Associates, a firm providing a wide array of Washington representational services for clients. He is the National Coordinator of the 3000 member Elder Justice Coalition.  He serves as Executive Director of the National Association of Nutrition and Aging Services Programs.

Conversations Contributors - Mary Grealy

Mary Grealy is president of the Healthcare Leadership Council, a coalition of chief executives of the nation’s leading healthcare companies and organizations.  The HLC advocates consumer-centered healthcare reform, emphasizing the value of private sector innovation.  It is the only health policy advocacy group that represents all sectors of the healthcare industry.  She was appointed to the position in August 1999.

Conversations Contributors - Freda Lewis-Hall

As Chief Medical Officer of Pfizer, Freda Lewis-Hall leads a team of Pfizer Medical professionals responsible for ensuring the safe, effective and appropriate use of Pfizer’s medicines and vaccines. Trained as a psychiatrist, Dr. Lewis-Hall has held leadership roles in academia, medical research, front-line patient care, and at global biopharmaceutical companies including Vertex, Bristol-Myers Squibb and Eli Lilly.

Dr. William Chin to Lead PhRMA Science & Regulatory Affairs

WASHINGTON, D.C. (June 3, 2013) –  The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Dr. William Chin will become Executive Vice President of Science and Regulatory Affairs, effective July 1, 2013. Dr. Chin will report to PhRMA President and CEO John J. Castellani and serve as a member of the PhRMA Management Committee.


2013 PhRMA Chairman Bob HuginPhRMA frequently hosts and participates in online and in-person events that delve into the science, policy and regulatory issues critical to biopharmaceutical innovation and patient access to medicines.

Learn more about recent past events:

Health Care Innovation & US Economy


Subscribe to RSS - About